Cresco Labs logo

Cresco Labs(OTC) CRLBF

Market Cap$237.93MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2018)-85%
5 Year-93%
1 Year-52%
1 Month-18%
$0.65
+1.39%
+0.01Today
Cresco Labs last closing stock price
MetricPriceDate
Last closeUSD 0.642026-09-30
Cresco Labs stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-17.83%USD 0.782026-09-23
1 month-18.08%USD 0.782026-08-31
3 month-22.05%USD 0.822026-07-02
Year to date-48.05%USD 1.232025-12-31
1 year-51.74%USD 1.322025-09-30
3 year-68.52%USD 2.032023-09-29
5 year-92.86%USD 8.952021-10-01
Since inception-85.28%USD 4.342018-12-04

Cresco Labs Financials at a Glance

Market Cap

$237.93MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$651.52M

Net Income (TTM)

-$103.47M

EPS (TTM)

-$0.29

P/E Ratio

-2.19

Dividend

$0.00

Beta (Volatility)

0.91 (Low)

Price

$0.65

Volume

174,081

Open

$0.65

Previous Close

$0.64

Daily Range

$0.64 - $0.69

52-Week Range

$0.59 - $2.30

Estimated Earnings Date

Nov 5, 2026

CRLBF News

person holding gummy bear edible an inch from her mouth

4 Best CBD Stocks for 2026 and How to Invest

Keith SpeightsSep 14, 2026
A cannabis leaf on top of a $100 bill.

5 Best Cannabis ETFs for 2026 and How to Invest

Keith SpeightsAug 12, 2026
Person lighting and consuming a marijuana cigarette

If You'd Invested $1,000 in CRLBF 5 Years Ago, Here's How Much You'd Have Today

Eric VolkmanAug 30, 2025
A farmer holding a tablet in a hemp field.

The Best Cannabis Stock to Invest $1,000 in Right Now

David Jagielski, CPAApr 17, 2024
A person examining a cannabis plant.

2 Marijuana Companies That Have Recently Turned Profits

David Jagielski, CPAMar 27, 2024
A couple working inside of a greenhouse.

2 Cannabis Stocks to Buy Hand Over Fist in March

David Jagielski, CPAMar 9, 2024
farmer inspects marijuana plant in greenhouse

Where Will Cresco Labs Be in 3 Years?

Alex CarchidiOct 18, 2023
A couple working inside of a greenhouse.

3 Top Cannabis Stocks to Buy for September

David Jagielski, CPASep 8, 2023
Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cresco Labs

Cresco Labs Inc. is a leading company in the cannabis industry, focusing on cultivating medical-grade cannabis and manufacturing related products. The company is dedicated to regulatory compliance and developing condition-specific strains for both medical and adult-use consumers.

Products and Services
  • Cultivation of medical-grade cannabis
  • Manufacturing of cannabis-derived products
  • Distribution to medical and adult-use consumers
Growth Outlook
  • Revenue increased to $173.34 million in Q2 2026
  • Gross profit margin improved to 50.2% in Q2 2026
  • Focus on expanding product offerings and market reach
Financial Highlights
  • Net income of $16.8 million reported in Q2 2026
  • Operating income of $13.36 million in Q2 2026
  • Current ratio of 1.78 indicates strong liquidity position
Cresco Labs Inc. operates in the rapidly growing cannabis sector, which has seen significant demand and regulatory changes. The company's commitment to quality and compliance positions it well for future growth. Recent financial performance shows a positive trend, with increasing revenue and improving profit margins. The focus on expanding product offerings and market reach further enhances the company's growth potential. Investors may find Cresco Labs Inc. an intriguing opportunity within the cannabis industry.
AI Generated • Sep 19, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

2,900

CEO

Charles Bachtell

Website

www.crescolabs.com

Headquarters

Chicago, IL 60661, US

CRLBF Financials

Key Financial Metrics (TTM)

Gross Margin

48.41%

Operating Margin

9.83%

Net Income Margin

-15.88%

Return on Equity

-28.27%

Return on Capital

10.74%

Return on Assets

-8.19%

Earnings Yield

-45.66%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$237.93MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

372.35M

Volume

174.08K

Avg. Volume

523.92K

Financials (TTM)

Gross Profit

$315.42M

Operating Income

$64.02M

EBITDA

$104.07M

Operating Cash Flow

$43.43M

Capital Expenditure

-$33.29M

Free Cash Flow

$10.14M

Cash & ST Invst.

$32.87M

Total Debt

$592.02M

Cresco Labs Performance Analysis

Cresco Labs annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 842,681,0002.6%
20232023-12-31USD 770,885,000-8.5%
20242024-12-31USD 724,343,000-6.0%
20252025-12-31USD 655,847,000-9.5%
Cresco Labs sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-300.8%
Q42025-12-31-0.5%
Q12026-03-31-9.0%
Q22026-06-3016.2%
Cresco Labs annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.71-41.6%
20232023-12-31USD -0.54-23.8%
20242024-12-31USD -0.22-60.2%
20252025-12-31USD -0.3877.0%
Cresco Labs sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-3.0%
Q42025-12-31-468.4%
Q12026-03-3186.9%
Q22026-06-30213.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$173.34M

+5.9%

Gross Profit

$86.95M

+4.4%

Gross Margin

50.16%

N/A

Market Cap

$237.93MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$82.05K

N/A

Employees

2,900

N/A

Net Income

$16.80M

+202.8%

EBITDA

$26.54M

-13.5%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$32.87M

-77.6%

Total Debt

$592.02M

-6.2%

Accounts Receivable

$39.88M

+1.0%

Inventory

$111.17M

+24.7%

Long Term Debt

$566.24M

-6.8%

Short Term Debt

$25.78M

+10.0%

Return on Assets

-8.19%

N/A

Return on Invested Capital

5.69%

N/A

Free Cash Flow

$5.90M

+232.0%

Operating Cash Flow

$14.94M

+69.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NWBONorthwest Biotherapeutics, Inc.
$0.15+1.63%
PTCHFPureTech Health plc
$1.54+0.00%
VRNOFVerano Holdings Corp.
$1.30+8.33%
ABTIAlterola Biotech, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$32.74-1.03%
SPDNDirexion Shares ETF Trust - Direxion Daily S&P 500 Bear 1x ETF
$8.50+0.18%
NXLNexalin Technology
$7.37+72.19%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$149.07+0.82%

Questions About CRLBF

What is the current price of Cresco Labs?

Cresco Labs is trading at $0.65 per share.

What is the 52-week range for Cresco Labs?

Over the past 52 weeks, Cresco Labs has traded between $0.59 and $2.30.

How much debt does Cresco Labs have?

As of the most recent reporting period, Cresco Labs reported total debt of $592.02M.

How much cash does Cresco Labs have on hand?

Cresco Labs reported $64.11M in cash and cash equivalents in its most recent financial results.

What is Cresco Labs’s dividend yield?

Cresco Labs does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services